fosaprepitant
Showing 1 - 18 of 18
Postoperative Nausea and Vomiting, Gynecologic Surgical Procedures, Laparoscopy Trial (fosaprepitant, normal saline)
Not yet recruiting
- Postoperative Nausea and Vomiting
- +2 more
- fosaprepitant
- normal saline
- (no location specified)
Mar 16, 2023
Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,
Recruiting
- Cervical Cancer
- +4 more
- Fosaprepitant
- +2 more
-
Shantou, Guangdong, ChinaCancer Hospital of Shantou University Medical College
Sep 29, 2022
Chemo Induced Nausea and Vomiting Pediatric Cancer Patients Trial in Shanghai (Fosaprepitant, Placebo(normal saline))
Not yet recruiting
- Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients
- Fosaprepitant
- Placebo(normal saline)
-
Shanghai, ChinaShanghai Children's Medical Center
Jan 28, 2022
Traumatic Brain Injury Trial (Fosaprepitant)
Withdrawn
- Traumatic Brain Injury
- Fosaprepitant
- (no location specified)
Oct 31, 2022
Pediatric Cancer Trial (Fosaprepitant, ondansetron with dexamethasone)
Not yet recruiting
- Pediatric Cancer
- Fosaprepitant
- placebo ondansetron with dexamethasone
- (no location specified)
Sep 1, 2021
Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)
Not yet recruiting
- Breast Cancer
- Chemotherapy-induced Nausea and Vomiting
- Aprepitant
- +2 more
-
Hanzhou, Zhejiang, Chinathe Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023
Chemo Induced Nausea and Vomiting, Pediatric Cancer Patients Trial in Shanghai (fosaprepitant, aprepitant, Granisetron plus
Not yet recruiting
- Chemotherapy Induced Nausea and Vomiting
- Pediatric Cancer Patients
- fosaprepitant
- +2 more
-
Shanghai, ChinaShanghai Children's Medical Center
May 5, 2021
Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)
Completed
- Multiple Myeloma
- Selinexor
- +4 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (fosaprepitant)
Recruiting
- Nasopharyngeal Carcinoma
- fosaprepitant
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 17, 2020
Chemo-induced Nausea and Vomiting (CINV) Trial (Granisetron transdermal patch, Palonosetron, Aprepitant)
Not yet recruiting
- Chemotherapy-induced Nausea and Vomiting (CINV)
- Granisetron transdermal patch
- +4 more
- (no location specified)
Jun 2, 2021
CINV Trial in Odense (Ondansetron, Placebo, Dexamethasone)
Chemo-induced Nausea and Vomiting Trial (Fosaprepitant, Fosaprepitant Placebo, Ondansetron)
Completed
- Chemotherapy-induced Nausea and Vomiting
- Fosaprepitant
- +3 more
- (no location specified)
Jun 14, 2019
Nausea and Vomiting, Postoperative Trial in Rio de Janeiro (Palonosetron, Fosaprepitant)
Unknown status
- Nausea and Vomiting, Postoperative
- Palonosetron
- Fosaprepitant
-
Rio de Janeiro, BrazilHospital Federal de Bonsucesso
Mar 10, 2019
Chemo-induced Nausea and Vomiting Trial (Fosaprepitant, Placebo for fosaprepitant, Ondansetron)
Terminated
- Chemotherapy-induced Nausea and Vomiting
- Fosaprepitant
- +4 more
- (no location specified)
Feb 28, 2019
Ovarian Cancer, Uterine Cancer Trial in Newport Beach (fosaprepitant, aprepitant, Oral Placebo)
Completed
- Ovarian Cancer
- Uterine Cancer
- fosaprepitant
- +3 more
-
Newport Beach, CaliforniaGynecologic Oncology Associates
Feb 24, 2017
Chemo-induced Nausea and Vomiting Trial in United States (APF530, Ondansetron, Ondansetron )
Completed
- Chemotherapy-induced Nausea and Vomiting
- APF530
- +5 more
-
Pheonix, Arizona
- +6 more
Oct 31, 2016
Chemo-Induced Nausea and Vomiting Trial in United States (Fosaprepitant, Dexamethasone, 5HT3)
Completed
- Chemotherapy-Induced Nausea and Vomiting
- Fosaprepitant
- +2 more
-
Indianapolis, Indiana
- +3 more
Apr 18, 2016
Sarcoma, Chemo-induced Nausea and Vomiting, Effects of Chemo Trial in Houston (Fosaprepitant, Dexamethasone, 5HT3 receptor
Completed
- Sarcoma
- +3 more
- Fosaprepitant
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 11, 2016